Invention Grant
- Patent Title: Use of pridopidine for treating functional decline
-
Application No.: US15685993Application Date: 2017-08-24
-
Publication No.: US11207310B2Publication Date: 2021-12-28
- Inventor: Michael Hayden , Spyridon Papapetropoulos , Juha-Matti Savola , Eli Eyal , Beth Borowsky , Igor Grachev
- Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
- Applicant Address: IL Herzliya
- Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
- Current Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
- Current Assignee Address: IL Herzliya
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61K31/451
- IPC: A61K31/451 ; A61K9/00

Abstract:
This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human patient comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine such that a dose of 90-225 mg of pridopidine is administered to the patient per day, so as to thereby maintain functional capacity, improve functional capacity, or lessen the decline of functional capacity in the human patient.
Public/Granted literature
- US20180055832A1 USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE Public/Granted day:2018-03-01
Information query
IPC分类: